Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Norway
Norway: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.0% in 2024. ◆ Volatile
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Norway, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
The most recent figure for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Norway is 0.0%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 100.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Norway peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2020.
That places Norway 168th out of 247 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.1% | +0.0% |
| 2018 | 0.1% | +0.0% |
| 2019 | 0.1% | +0.0% |
| 2020 | 0.0% | -100.0% |
| 2021 | 0.0% | — |
| 2022 | 0.0% | — |
| 2023 | 0.0% | — |
| 2024 | 0.0% | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.0% | 0.0% | 0.0% | 5 |
Countries ranked near Norway
- 168 Andorra 0.0%
- 168 Argentina 0.0%
- 168 Austria 0.0%
- 168 Bahrain 0.0%
- 168 Belarus 0.0%
- 168 Belgium 0.0%
- 168 Bermuda 0.0%
- 168 Brazil 0.0%
- 168 Bulgaria 0.0% compare
- 168 Canada 0.0%
- 168 Chile 0.0%
- 168 Colombia 0.0%
- 168 Cook Islands 0.0%
- 168 Costa Rica 0.0%
- 168 Croatia 0.0%
- 168 Cuba 0.0%
- 168 Czechia 0.0%
- 168 Ecuador 0.0%
- 168 Egypt 0.0% compare
- 168 El Salvador 0.0%
- 168 Estonia 0.0%
- 168 Falkland Islands (Malvinas) 0.0%
- 168 Faroe Islands 0.0% compare
- 168 Finland 0.0%
- 168 France 0.0%
- 168 French Guiana 0.0%
- 168 French Polynesia 0.0% compare
- 168 Georgia 0.0%
- 168 Germany 0.0%
- 168 Gibraltar 0.0%
- 168 Greece 0.0%
- 168 Greenland 0.0%
- 168 Guatemala 0.0% compare
- 168 Guernsey 0.0% compare
- 168 Holy See 0.0%
- 168 Honduras 0.0%
- 168 Iceland 0.0% compare
- 168 Iran (Islamic Republic of) 0.0%
- 168 Ireland 0.0%
- 168 Isle of Man 0.0% compare
- 168 Italy 0.0%
- 168 Japan 0.0% compare
- 168 Jersey 0.0% compare
- 168 Kuwait 0.0%
- 168 Latvia 0.0% compare
- 168 Liechtenstein 0.0%
- 168 Luxembourg 0.0%
- 168 Malta 0.0% compare
- 168 Mexico 0.0%
- 168 Monaco 0.0%
- 168 Montenegro 0.0%
- 168 Morocco 0.0%
- 168 Netherlands (Kingdom of the) 0.0%
- 168 New Zealand 0.0% compare
- 168 Nicaragua 0.0% compare
- 168 Niue 0.0%
- 168 Panama 0.0%
- 168 Poland 0.0%
- 168 Portugal 0.0%
- 168 Qatar 0.0% compare
- 168 Republic of Korea 0.0% compare
- 168 Saint Pierre and Miquelon 0.0%
- 168 San Marino 0.0%
- 168 Saudi Arabia 0.0%
- 168 Slovakia 0.0%
- 168 Slovenia 0.0% compare
- 168 Spain 0.0%
- 168 State of Palestine 0.0% compare
- 168 Sweden 0.0%
- 168 Switzerland 0.0% compare
- 168 Tokelau 0.0%
- 168 Türkiye 0.0% compare
- 168 United Arab Emirates 0.0%
- 168 United Kingdom of Great Britain and Northern Ireland 0.0% compare
- 168 Uruguay 0.0%
- 168 South Korea 0.0% compare
- 168 Turkey 0.0% compare
- 168 United Kingdom 0.0% compare
- 168 United States 0.0%
More development goals data for Norway
- Red List Index 0.9513 (2025)
- Number of refugees per 100,000 population, by country of origin 0.1778 (2025)
- Manufacturing value added per capita 4,698 (2025)
- Number of transboundary breeds 30 (2025)
- Number of transboundary breeds (not extinct) 30 (2025)
- Number of transboundary breeds with unknown risk status 0 (2025)
- Number of local breeds with unknown risk status 1 (2025)
- Number of local breeds (not extinct) 47 (2025)
- Number of local breeds kept in the country 47 (2025)
- Infant deaths 106 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Norway?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Norway was 0.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Norway?
- The highest recorded value was 0.1% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Norway?
- The lowest recorded value was 0.0% in 2020.
- How does Norway rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Norway ranks 168th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Norway?
- Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
- Where does this Norway data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).